Going Beyond GLP-1 Therapy in T2D with Omnipod 5 Note: Davida Kruger has a commercial relationship with Insulet
The Leyden 2002 facial-cream trial reported skin density, thickness, fine lines, and laxity changes at 12 weeks
Emerging evidence demonstrates that GLP-1 receptors are expressed in Type II taste cells, where they modulate sweet sensitivity through the G-gustducin/TRPM5 pathway, and downregulate T1R2/T1R3 expression and ATP release (164, 165)
doi: 10.3390/life15091422 9 d'AielloA.BonanniA.VinciR.PedicinoD.SeverinoA.De VitaA.et al
PT 141 is a melanocortin receptor agonist that targets the MC3R and MC4R receptors in the central nervous system
Scientists are studying ways to manage inflammation, and one area of research focuses on BPC-157 Peptide Nasal Spray